Evidence map›Paper›PMID 33176717›Full record

ArticleBMC infectious diseases2020

Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report.

Arezki Izri, Mohanad Aljundi, Typhaine Billard-Pomares, Youssouf Fofana, Anthony Marteau, Theo Ghelfenstein Ferreira, Sophie Brun, Frederic Caux, Mohammad Akhoundi

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. A scoping review of mycetoma profile in Egypt: revisiting the global endemicity map.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2023
    Article
  2. A Rare StrainInfection and drug resistance · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Arezki IzriParasitology-Mycology Department, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France.
Mohanad AljundiDermatology Department, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France.
Typhaine Billard-PomaresBacteriology Department, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France.
Youssouf FofanaDermatology Department, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France.
Anthony MarteauParasitology-Mycology Department, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France.
Theo Ghelfenstein FerreiraParasitology-Mycology Department, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France.
Sophie BrunParasitology-Mycology Department, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France.
Frederic CauxDermatology Department, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France.
Mohammad AkhoundiParasitology-Mycology Department, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France. m.akhoundi@yahoo.com.ORCID http://orcid.org/0000-0003-4672-9836
Université Sorbonne Paris Nord · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMycetoma is a chronic granulomatous subcutaneous infection caused by anaerobic pseudofilamentous bacteria or fungi. It is commonly prevalent in tropical and subtropical countries. Men are more susceptible to the disease due to greater participation in agricultural works. Mycetoma commonly involves lower extremities, wherein untreated cases lead to aggressive therapeutic choices, such as amputation of the affected body organs and consequently lifelong disability. CASE PRESENTATION: In this report, we present the rare case of a 58-year-old man, originally from Algeria with a left foot chronic tumefaction of 5 years. In the initial clinical examination, mycetoma was diagnosed based on tumefaction and the presence of multiple sinuses with the emission of white grains. The latter was observed via direct examination. The histopathological analysis demonstrated an actinomycetoma caused by bacteria, as the etiological agent. Imaging showed a bone involvement with osteolysis at the levels of 2nd to 4th metatarsal diaphysis. The mycological and bacterial cultures were both negative. For an accurate diagnosis, the obtained grains were subjected to molecular analysis, targeting the 16S-rDNA gene. Molecular identification yielded Actinomadura madurae as the causal agent, and 800/160 mg of trimethoprim/sulfamethoxazole was prescribed twice a day for 1 year, as a treatment.

conclusionConsidering low information about this disease, especially in non-endemic areas, it is of high importance to enhance the knowledge and awareness of clinicians and healthcare providers, in particular in the countries with immigration issues.

Indexed as

ActinobacteriaActinomaduraAlgeriaAnti-Bacterial AgentsDNA, RibosomalEmigrants and ImmigrantsFootHumansMaleMiddle AgedMycetomaParisTreatment OutcomeTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsDNA, RibosomalTrimethoprim, Sulfamethoxazole Drug CombinationActinomycetomaImaging; case reportMadura footMolecular identificationWhite grains

Identifiers

PMID33176717
PMCPMC7656693
OpenAlexW3100448840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.